Research programme: beta-lactamase inhibitors - Wyeth
Alternative Names: Penem inhibitors of OXA beta-lactamases - WyethLatest Information Update: 03 Oct 2011
At a glance
- Originator Wyeth
- Class Penems
- Mechanism of Action Beta lactamase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Bacterial infections
Most Recent Events
- 28 Sep 2007 Preclinical development is ongoing
- 19 Dec 2005 Preclinical trials in Bacterial infections in Japan (unspecified route)
- 12 Nov 2004 Data presented at the 44th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC-2004) have been added to the Bacterial Infections antimicrobial activity section